Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of different origins Underscores Radiopharm’s commitment to developing transformative oncology radiopharmaceuticals Radiopharm Theranostics (ASX:RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high…
John Ciampaglia, CEO of Sprott Asset Management, shares his outlook for the gold price. ‘To us, gold could continue…
Sarama Resources (SRR:AU) has announced Initial Exploration Program Completed at Cosmo Gold Project Download the PDF here. This post…
‘Never miss out on an opportunity like a recession’ — Jack Welch, former chairman and CEO of General Electric.…
Continuing his administration’s push toward reducing US reliance on Chinese mineral imports, President Donald Trump has signed a new…
It was quite a week for the gold price. The yellow metal continued its record-breaking streak early in the…
The American economy may be heading toward stagflation, an environment characterized by high inflation, slowing growth and rising unemployment,…